10-K Decoder · All companies

United Therapeutics Corporation

UTHR · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$3.18B$2.88B+10.6%
Operating income$1.49B$1.38B+8.4%
Net income$1.33B$1.20B+11.7%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$832M$800M+4.1%
Operating income$308M$388M−20.8%
Net income$259M$339M−23.6%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was United Therapeutics's revenue in FY2025?
$3.18B in FY2025 (Fiscal year ended Dec 31, 2025), +10.6% vs $2.88B a year earlier, per its 10-K filed Feb 2026.
Was United Therapeutics profitable in FY2025?
Yes: net income was $1.33B and operating income $1.49B in FY2025.
What was United Therapeutics's revenue in Q3 2026?
$832M (+4.1% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.